An animal study showed that pioglitazone significantly elevated serum and hepatic SHBG levels, considerably improving triglyceride and total cholesterol levels, insulin resistance, and hyperandrogenemia in rats with polycystic ovary syndrome (40). Here, SHBG is linked to polycystic ovary syndrome.